G3BP2 and endothelial dysfunction: MiR-124-3p can inhibit high glucose-induced endothelial dysfunction by targeting G3BP2 and activating p38MAPK signaling.[51] The expression of hsa-miR-124-3p in the serum of patients with acute ischemic stroke is downregulated.